关注
Willem Talloen
Willem Talloen
Director, Janssen Pharmaceutcials group
在 its.jnj.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
FABIA: factor analysis for bicluster acquisition
S Hochreiter, U Bodenhofer, M Heusel, A Mayr, A Mitterecker, A Kasim, ...
Bioinformatics 26 (12), 1520-1527, 2010
3872010
JNJ-26481585, a novel second-generation oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity
J Arts, P King, A Marin, W Floren, A Belin, L Janssen, I Pilatte, B Roux, ...
Clinical Cancer Research 15 (22), 6841-6851, 2009
2402009
The cost of melanization: Butterfly wing coloration underenvironmental stress
W Talloen, HV Dyck, L Lens
Evolution 58 (2), 360-366, 2004
1982004
Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome
J Aerssens, M Camilleri, W Talloen, L Thielemans, HWH Göhlmann, ...
Clinical Gastroenterology and Hepatology 6 (2), 194-205, 2008
1682008
I/NI-calls for the exclusion of non-informative genes: a highly effective filtering tool for microarray data
W Talloen, DA Clevert, S Hochreiter, D Amaratunga, L Bijnens, S Kass, ...
Bioinformatics 23 (21), 2897-2902, 2007
1542007
Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection
MF Yuen, EJ Gane, DJ Kim, F Weilert, HLY Chan, J Lalezari, SG Hwang, ...
Gastroenterology 156 (5), 1392-1403. e7, 2019
1392019
Quantitation of pretreatment serum interferon‐γ–inducible protein‐10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment …
JM Darling, J Aerssens, G Fanning, JG McHutchison, DB Goldstein, ...
Hepatology 53 (1), 14-22, 2011
1342011
Functional conservation units for the endangered Alcon Blue butterfly Maculinea alcon in Belgium (Lepidoptera: Lycaenidae)
D Maes, W Vanreusel, W Talloen, H Van Dyck
Biological Conservation 120 (2), 229-241, 2004
1312004
Gene expression studies using Affymetrix microarrays
H Gohlmann, W Talloen
Chapman and Hall/CRC, 2009
1112009
Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR project
B Verbist, G Klambauer, L Vervoort, W Talloen, Z Shkedy, O Thas, ...
Drug discovery today 20 (5), 505-513, 2015
1072015
Does the presence of ant nests matter for oviposition to a specialized myrmecophilous Maculinea butterfly?
H Dyck, JGB Oostermeijer, W Talloen, V Feenstra, A Hidde, I Wynhoff
Proceedings of the Royal Society of London. Series B: Biological Sciences …, 2000
1072000
JNJ-56136379, an HBV capsid assembly modulator, is well-tolerated and has antiviral activity in a phase 1 study of patients with chronic infection
F Zoulim, O Lenz, JJ Vandenbossche, W Talloen, T Verbinnen, I Moscalu, ...
Gastroenterology 159 (2), 521-533. e9, 2020
1012020
Microcontaminant accumulation, physiological condition and bilateral asymmetry in zebra mussels (Dreissena polymorpha) from clean and contaminated surface waters
J Voets, W Talloen, T de Tender, S Van Dongen, A Covaci, R Blust, ...
Aquatic Toxicology 79 (3), 213-225, 2006
742006
Genome‐wide copy number alterations detection in fresh frozen and matched FFPE samples using SNP 6.0 arrays
M Tuefferd, A De Bondt, I Van Den Wyngaert, W Talloen, T Verbeke, ...
Genes, Chromosomes and Cancer 47 (11), 957-964, 2008
732008
VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering
BMP Verbist, K Thys, J Reumers, Y Wetzels, K Van der Borght, W Talloen, ...
Bioinformatics 31 (1), 94-101, 2015
702015
EEG alpha power as an intermediate measure between brain-derived neurotrophic factor Val66Met and depression severity in patients with major depressive disorder
HFA Zoon, CPM Veth, M Arns, W Drinkenburg, W Talloen, PJ Peeters, ...
Journal of Clinical Neurophysiology 30 (3), 261-267, 2013
592013
Response prediction to a multitargeted kinase inhibitor in cancer cell lines and xenograft tumors using high-content tyrosine peptide arrays with a kinetic readout
M Versele, W Talloen, C Rockx, T Geerts, B Janssen, T Lavrijssen, P King, ...
Molecular cancer therapeutics 8 (7), 1846-1855, 2009
582009
Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled …
K Hardt, A Vandebosch, J Sadoff, M Le Gars, C Truyers, D Lowson, ...
The Lancet Infectious Diseases 22 (12), 1703-1715, 2022
512022
Applied biclustering methods for big and high dimensional data using R
Z Shkedy, S Kaiser, S Hochreiter, W Talloen
CRC Press Taylor & Francis Group, 2016
462016
Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis
AC Ravindranath, N Perualila-Tan, A Kasim, G Drakakis, S Liggi, ...
Molecular BioSystems 11 (1), 86-96, 2015
392015
系统目前无法执行此操作,请稍后再试。
文章 1–20